Document is current
Any future updates will be listed below
-
Authors
Sammut, Stephen-John http://orcid.org/0000-0003-4472-904X
Crispin-Ortuzar, Mireia
Chin, Suet-Feung http://orcid.org/0000-0001-5697-1082
Provenzano, Elena http://orcid.org/0000-0003-3345-3965
Bardwell, Helen A.
Ma, Wenxin
Cope, Wei
Dariush, Ali
Dawson, Sarah-Jane http://orcid.org/0000-0002-8276-0374
Abraham, Jean E.
Dunn, Janet
Hiller, Louise
Thomas, Jeremy http://orcid.org/0000-0002-4652-610X
Cameron, David A.
Bartlett, John M. S.
Hayward, Larry
Pharoah, Paul D. http://orcid.org/0000-0001-8494-732X
Markowetz, Florian http://orcid.org/0000-0002-2784-5308
Rueda, Oscar M. http://orcid.org/0000-0003-0008-4884
Earl, Helena M.
Caldas, Carlos http://orcid.org/0000-0003-3547-1489
- License Information
-
More Information
Article History
Received: 30 July 2021
Accepted: 23 November 2021
First Online: 7 December 2021
Competing interests
: C.C. is a member of the iMED External Science Panel for AstraZeneca, a member of the Scientific Advisory Board for Illumina and a recipient of research grants (administered by the University of Cambridge) from Genentech, Roche, AstraZeneca and Servier. M.C.-O. has received research funding from Lilly. All other authors declare no competing interests.
